Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer

J Am Geriatr Soc. 2010 May;58(5):986-8. doi: 10.1111/j.1532-5415.2010.02833.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Celecoxib
  • Cyclooxygenase 2 Inhibitors / administration & dosage
  • Cyclophosphamide / administration & dosage*
  • Dexamethasone / administration & dosage
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Pyrazoles / administration & dosage
  • Retrospective Studies
  • Sulfonamides / administration & dosage

Substances

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Hormonal
  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Dexamethasone
  • Cyclophosphamide
  • Celecoxib